PITTSBURGH — FEB. 17, 2025 — OraBio, the company responsible for bringing the revolutionary Periovance Dry Mouth Oral Moisturizing Gel to market, is pleased to announce the appointment of John J. Hauck to position of Chief Executive Officer and Board Member.
Hauck’s last 10 years in the healthcare industry have granted him extensive experience in consultative sales, negotiation, commercial marketing, product management, and strategic relationships. Under orthopedic market leaders, including Zimmer Biomet, Arthrex, and Smith & Nephew, he’s pioneered successful brand campaigns and product launches within the highly competitive sector. Hauck has also negotiated the placement of cutting-edge surgical robotics into many of the world’s leading academic medical centers.
In addition to an MBA from Boston College, Hauck graduated from Stonehill College with a publication and degrees in Biochemistry and Economics. He currently lives with his wife and daughter in the Boston area.

Hauck states “This is an exciting time for OraBio, coming off two product launches in 2024 and commercializing the Periovance brand. I look forward to seeing the relief that Periovance will provide to patients struggling with Xerostomia and other periodontal diseases as we continue to grow in this market segment. In my career in the healthcare industry, improving patient outcomes by getting cutting-edge technology into the hands of providers has always been where I have found my passion. The OraBio team exemplifies what it means to put patients first. Their dedication to oral health innovation and clinical education is second to none and I could not be more excited to join this team. ”
About OraBio
Founded in 2021, OraBio discovers, develops, and commercializes the latest in oral health innovations that improve patient outcomes. OraBio’s initial flagship brand, Periovance, offers products that address the patient’s periodontal journey from diagnosis, prevention, and treatment of gingivitis, periodontitis, and associated conditions. The company also is focused on identifying and bringing dental innovations to the market in a faster, more effective manner.